Kimia Biosciences Limited
About
Overview
Vision & Mission
Our Future
Our achievements
Team
Infrastructure
Quality
Facilities
Research & Developments
Products
APIs
Intermediates
Formulations
Investor Relations
Composition of BOD & Committees
Statutory Communication
2022
2021
2020
2019
2018
2017
2016
Annual Reports
Quarterly Results
Shareholding Pattern
Code of Conduct
Corporate Governance
Investor Grievances
Policies
Scheme of Amalgamation
Drafts and Formats for KYC Updation
Careers
Life at Kimia
Job Openings
Training & Safety
Menu
About
Overview
Vision & Mission
Our Future
Our achievements
Team
Infrastructure
Quality
Facilities
Research & Developments
Products
APIs
Intermediates
Formulations
Investor Relations
Composition of BOD & Committees
Statutory Communication
2022
2021
2020
2019
2018
2017
2016
Annual Reports
Quarterly Results
Shareholding Pattern
Code of Conduct
Corporate Governance
Investor Grievances
Policies
Scheme of Amalgamation
Drafts and Formats for KYC Updation
Careers
Life at Kimia
Job Openings
Training & Safety
Search
Close
Our Achievements
Accreditations
ISO -14001.2015
ISO-9001.2015
ISO- 18001.2007
WHO -GMP
COPP
Department of Science & technology, Govt. Of India
Korean FDA - Under Approval
Approvals
Prucalopride Succinate
Azenidipine
Acotiamide Hydrochloride Hydrate
Fimasartan Potassium Trihydrate
Obeticholic Acid